MODASMART 200

What is MODASMART 200?

MODASMART 200 is an oral tablet medication containing the active ingredient modafinil at a dosage of 200 mg. The drug belongs to the pharmacological group of psychostimulants and wakefulness-promoting agents, although its mechanism of action differs significantly from classic amphetamine-type stimulants. The manufacturer of MODASMART 200 is the pharmaceutical company Winlife Pharma, which specializes in the production of drugs in the ASSURANS, CENFORCE, and MALEGRA categories. The product is designed to correct pathological excessive sleepiness and restore a physiological level of alertness during the day. In medical practice, modafinil is considered an atypical central nervous system stimulant with a relatively favorable safety profile.

The pharmacological action of MODASMART 200 is realized through its effect on the brain's neurotransmitter systems, specifically on the metabolism of dopamine, norepinephrine, histamine, and orexin. Unlike traditional psychostimulants, the drug does not cause marked euphoria, a sharp increase in blood pressure, or significant psychomotor agitation. This allows it to be used for long-term therapy in patients requiring stable control over daytime sleepiness. The therapeutic effect develops gradually and persists for 12–15 hours after administration. It is important to understand that MODASMART 200 does not replace full sleep, but only helps maintain wakefulness in cases where sleepiness is pathological.

The medication is produced in the form of white or almost white tablets with a score line for convenient splitting. Each tablet contains a precisely measured dose of modafinil, ensuring predictable pharmacokinetics and a stable clinical result. MODASMART 200 is available by prescription, as it belongs to medications requiring medical supervision. Self-medication with this drug is unacceptable, as improper dosage can lead to sleep disturbances, anxiety, or cardiovascular reactions. Before starting therapy, a consultation with a specialist is mandatory to assess the appropriateness of the prescription and select an individual regimen.

What is MODASMART 200 prescribed for?

The primary indication for the use of MODASMART 200 is narcolepsy — a chronic neurological disorder characterized by uncontrollable sleep attacks during the day. In such patients, the medication helps reduce the frequency and intensity of sudden falling asleep episodes, allowing them to lead a more active lifestyle. Clinical studies demonstrate that modafinil significantly increases daytime alertness after the very first days of therapy. The effect persists throughout the treatment period without the development of marked tolerance. This makes MODASMART 200 one of the first-line drugs for long-term control of narcolepsy.

The second important indication is obstructive sleep apnea syndrome, in which patients suffer from severe daytime sleepiness even after nighttime use of CPAP therapy. MODASMART 200 is used as an adjunctive treatment to reduce residual sleepiness and improve quality of life. The drug does not treat apnea itself, but effectively eliminates its consequence — pathological fatigue and the need for daytime sleep. Doctors prescribe it only after confirming the diagnosis and provided the patient adheres to the primary therapy. This approach allows achieving the maximum therapeutic result.

MODASMART 200 is also used for shift work sleep disorder, when professional activity requires alertness at night. The drug helps adapt the body to an atypical schedule, reducing sleepiness during work shifts and improving concentration. In some cases, a physician may prescribe modafinil for severe fatigue associated with depressive states or multiple sclerosis; however, such use is off-label and requires special caution. The decision to prescribe the medication is always made by a doctor based on a comprehensive clinical examination.

Composition and active ingredients of MODASMART 200

The main active ingredient of MODASMART 200 is modafinil — a synthetic compound belonging to the class of benzhydrylsulfinylacetamides. Its mechanism of action consists in selectively increasing dopamine concentration in the synaptic cleft by blocking the dopamine transporter. This leads to the activation of dopamine receptors in the hypothalamus and cerebral cortex responsible for maintaining wakefulness. Unlike amphetamines, modafinil does not cause a massive release of monoamines, so its stimulating effect is milder and more controlled. Additionally, the drug affects the histamine and orexin systems, enhancing alertness signals.

The MODASMART 200 tablet formulation also includes excipients that ensure shape stability, proper bioavailability, and a long shelf life. Among them are lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, and magnesium stearate. Lactose acts as a filler, cellulose provides structural integrity to the tablet, and croscarmellose promotes rapid disintegration in the gastrointestinal tract. Magnesium stearate is used as a lubricating agent to prevent powder from adhering to compression equipment. All excipients comply with pharmacopeial quality standards.

The pharmacokinetics of modafinil are characterized by rapid absorption after oral administration, reaching peak plasma concentration in 2–3 hours. The elimination half-life is approximately 12–15 hours, allowing the medication to be taken once daily. Metabolism occurs primarily in the liver with the participation of cytochrome P450 system enzymes, particularly CYP3A4. Excretion of metabolites is carried out by the kidneys, so patients with impaired renal function may require dose adjustment. A steady-state concentration of the active substance in the blood is achieved on the third or fourth day of regular administration.

Dosage of MODASMART 200

The standard recommended dose of MODASMART 200 for adult patients is 200 mg once daily. The medication should be taken in the morning or one hour before starting a work shift in the case of shift work. For patients with narcolepsy, this dose usually provides adequate control of daytime sleepiness throughout the day. In case of insufficient efficacy, a doctor may consider increasing the dose to 400 mg per day, divided into two doses. However, such a decision is made exclusively on an individual basis, taking into account tolerability and clinical response.

For elderly patients or individuals with impaired liver function, the initial dose may be reduced to 100 mg per day. This allows assessing the body's individual reaction and minimizing the risk of side effects. The duration of treatment is determined by the physician depending on the underlying condition and can range from several weeks to a prolonged period. MODASMART 200 is not intended for continuous use without medical supervision, as it requires periodic evaluation of efficacy and safety. Abrupt cessation is usually not accompanied by a marked withdrawal syndrome; however, a gradual reduction in dose is more advisable.

The maximum daily dose should not exceed 400 mg, as a further increase does not lead to a proportional increase in therapeutic effect but raises the likelihood of adverse reactions. Patients with severe renal impairment are recommended to halve the dose. If a regular dose is missed, the next one should not be doubled; simply continue taking it according to the usual schedule. Dosage adjustment is carried out only after consulting a doctor who has complete information about the patient's condition and concomitant therapy.

How to take MODASMART 200 correctly?

MODASMART 200 is taken orally with a sufficient amount of water, regardless of meals. However, it should be noted that consuming fatty food can slow down the absorption of the drug and delay the onset of the effect by 1–2 hours. To achieve a stable therapeutic result, it is recommended to take the tablet at the same time every day. It is best to do this in the morning to avoid disrupting night sleep. If the medication is prescribed for night shift work, it is taken 30–60 minutes before the start of the shift.

During treatment with MODASMART 200, it is important to practice sleep hygiene and provide the body with sufficient night rest. The medication is not a substitute for sleep, so chronic sleep deprivation can lead to nervous system exhaustion even while taking the drug. Patients should avoid consuming caffeinated beverages in the afternoon, as this may enhance the stimulating effect and cause anxiety. It is also not recommended to take MODASMART 200 later than 12 hours before planned sleep. If insomnia occurs, inform your doctor to adjust the administration time or dosage.

If a dose is missed, it should be taken as soon as possible if there are more than 6 hours remaining until the next dose. If less time remains, the missed dose should be skipped, and the usual schedule resumed to avoid accumulation of the drug in the body. It is strictly forbidden to independently change the dosage or frequency of administration without agreeing with the doctor. MODASMART 200 is not intended for use by healthy individuals to increase productivity or academic performance. Such use is dangerous and can lead to serious health disorders.

Side effects of MODASMART 200

The most common side effects of MODASMART 200 are headache, nervousness, insomnia, and anxiety. These symptoms usually occur at the beginning of therapy and disappear during the first days of intake as the body adapts. Patients may also note decreased appetite, dry mouth, nausea, or dyspeptic disorders. The incidence of such reactions ranges from 5 to 10 percent of cases and rarely requires discontinuation of the drug. To reduce the severity of headaches, it is recommended to ensure adequate fluid intake and avoid excessive visual strain.

Uncommon side effects include tachycardia, increased blood pressure, palpitations, and chest pain. These manifestations require special attention in patients with cardiovascular diseases, so before prescribing MODASMART 200, the doctor must evaluate the condition of the heart. In rare cases, skin reactions are possible, including rash, itching, or hives. Particularly dangerous is the development of Stevens-Johnson syndrome or toxic epidermal necrolysis, requiring immediate drug withdrawal and emergency medical care. The appearance of any skin changes is a reason for urgent medical consultation.

Psychiatric reactions may include mood changes, irritability, depressive episodes, or, conversely, excessive agitation. Patients with a history of psychiatric disorders require special monitoring during therapy. Individual body reactions may vary, so if any unusual symptoms occur, inform your doctor immediately. In most cases, side effects are transient and do not pose a threat to life; however, unauthorized continuation of use in the presence of serious reactions is unacceptable. The doctor may adjust the dose or suggest an alternative drug.

Contraindications of MODASMART 200

MODASMART 200 has clear contraindications that must be considered before starting therapy. Absolute contraindications are hypersensitivity to modafinil or any excipient of the drug. The medication is not prescribed to patients with severe arterial hypertension, uncontrolled arrhythmias, ischemic heart disease, or a recent myocardial infarction. MODASMART 200 is also contraindicated in severe anxiety, psychomotor agitation, psychosis, or bipolar disorder in the manic phase. The presence of left ventricular hypertrophy or mitral valve prolapse with severe regurgitation is grounds for withholding the prescription.

Pregnancy and breastfeeding are absolute contraindications for the use of MODASMART 200. Animal studies have shown potential risk to the fetus, so the drug is not recommended for women of childbearing potential without reliable contraception. The drug is not prescribed to children and adolescents under 18 years of age due to the lack of sufficient safety and efficacy data. Patients with severe hepatic impairment should avoid modafinil or use it with extreme caution under close monitoring of liver function. A relative contraindication is a history of seizures, as the drug may lower the seizure threshold.

For elderly patients, MODASMART 200 is prescribed with caution, starting with minimal doses, due to an increased risk of cardiovascular complications. Persons with renal insufficiency require dosage adjustment and regular monitoring of renal function. Patients with a history of mental disorders require special attention, as modafinil can trigger an exacerbation of symptoms. Before starting therapy, a complete medical examination, including electrocardiography and blood pressure evaluation, is mandatory. Only a doctor can determine whether the expected benefit outweighs potential risks for a specific patient.

Interaction of MODASMART 200 with other drugs and alcohol

MODASMART 200 can interact with a number of medications, requiring caution during combined therapy. The drug is an inducer of CYP3A4 enzymes, so it can reduce the effectiveness of hormonal contraceptives, cyclosporine, certain antiviral, and anticonvulsant agents. Women taking oral contraceptives are recommended to use additional methods of contraception throughout the treatment period and for another month after its completion. Concomitant use with warfarin-type anticoagulants requires regular monitoring of blood clotting parameters. Patients must inform their doctor about all medications they are taking, including over-the-counter drugs and herbal supplements.

Alcohol consumption during treatment with MODASMART 200 is not recommended, as it can lead to unpredictable reactions from the central nervous system. Alcohol is capable of enhancing the side effects of the drug, particularly dizziness, impaired coordination, and drowsiness, or, conversely, causing excessive agitation. In addition, combining modafinil with alcohol creates an additional burden on the liver. During therapy, one should refrain from driving vehicles until the individual response to the drug becomes clear. If dizziness, visual disturbances, or slowed reaction time occur, driving should be avoided completely.

Where to buy MODASMART 200 in Ukraine

MODASMART 200 is available in Ukraine through a network of licensed pharmacies, as well as specialized online services delivering medications. Since the drug is dispensed by prescription, it is necessary to have a corresponding doctor's prescription for its purchase. This ensures that the patient receives an original product from the manufacturer Winlife Pharma with proper storage conditions and confirmed quality. It is recommended to buy MODASMART 200 only from verified suppliers who can provide certificates of conformity and documentation regarding the origin of the drug. Avoid dubious offers that do not require a prescription or offer understated prices, as this may indicate a counterfeit.

MODASMART 200 should be stored in a dry place protected from light at a temperature not exceeding 25 degrees Celsius. The medication must be kept out of reach of children and pets. The shelf life is usually 24–36 months from the date of manufacture, after which use is prohibited. Before purchasing, it is worth checking the availability of the drug in the pharmacy network or using the online reservation service. Remember that a responsible attitude towards buying and storing medicine is the key to effective and safe treatment. Consultation with a doctor before taking MODASMART 200 is mandatory, as only a specialist can evaluate the appropriateness of therapy and select the optimal dosage regimen considering the individual characteristics of the body.